FINWIRES · TerminalLIVE
FINWIRES

MannKind's Diversified Portfolio Seen Leading to Higher Revenue in H2, Wedbush Says

By

MannKind's (MNKD) increasingly diversified portfolio is seen bringing in higher revenue in H2, with 2026 being a "year of execution" on the commercial and clinical fronts, Wedbush said in a Thursday note.

The company plans to prioritize its Furoscix therapy, with its ReadyFlow autoinjector delivery system priced at around the same level as the on-body infusor but with a 70% higher gross margin, the firm said. MannKind stated that 2026 total net revenue could be nearer to the lower end of guidance of $110 million, but the inventory buying pattern may impact H2 revenue significantly, according to the note.

MannKind's partner United Therapeutics (UTHR) expects future demand for ralinepag DPI and Tyvaso DPI to require all of its manufacturing capacity, pointing to strong revenue potential, Wedbush said.

Further, MannKind plans to focus on the pediatric market in the near term for Afrezza after the drug's approval from the US Food and Drug Administration in May, the firm said.

Wedbush's rating on the company's stock is outperform with a price target of $8.

Price: $3.81, Change: $-0.29, Percent Change: -7.07%

Related Articles

Wire

Cirrus Logic Fiscal Q1 Adjusted Earnings, Revenue Rise

Cirrus Logic (CRUS) reported fiscal Q1 adjusted earnings late Wednesday of $1.84 per diluted share, up from $1.51 a year earlier.Analysts polled by FactSet expected $1.81.Revenue in the three months ended June 27 rose to $459.7 million from $407.3 million a year ago.Four analysts expected $460.3 million.The company expects fiscal Q2 revenue of $510 million to $570 million. Analysts project $570.1 million.Cirrus Logic shares fell 3.4% in after-hours trading.

$CRUS
Wire

Tenaris Q2 Earnings, Revenue Fall

Tenaris (TS) reported Q2 earnings late Wednesday of $0.95 per American depository share, down from $0.99 a year earlier.Four analysts polled by FactSet expected $0.83.Revenue in the three months ended June 30 fell to $2.97 billion from $3.09 billion a year earlier.Analysts expected $2.93 billion.Tenaris shares fell 5.5% in after-hours trading.

$TS
Wire

Block Q2 Adjusted Earnings, Revenue Rise

Block (XYZ) reported Q2 adjusted earnings late Wednesday of $1.02 per diluted share, up from $0.62 a year earlier.Analysts polled by FactSet expected $0.87.Revenue in the three months ended June 30 rose to $6.62 billion from $6.05 billion a year earlier.Analysts projected $6.47 billion.Block expects Q3 adjusted diluted EPS of $1.02. Analysts project $1.01.The company increased full-year adjusted EPS guidance to $4.02 from the prior outlook of $3.85. Analysts project $3.90.Block shares fell 1.7% in after-hours trading.

$XYZ